The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
Open accessAbstract
Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB. Through the use of high throughput whole cell screening of an extensive compound library a number of imidazo[1,2-a]pyridine (IP) compounds were obtained as potent lead molecules active against M. tuberculosis and Mycobacterium bovis BCG. The IP inhibitors (1-4) demonstrated minimum inhibitory concentrations (MICs) in the range of 0.03 to 5 µM against a panel of M. tuberculosis strains. M. bovis BCG spontaneous resistant mutants were generated against IP 1, 3, and 4 at 5× MIC and subsequent whole genome sequencing identified a single nucleotide polymorphism (937)ACC>(937)GCC (T313A) in qcrB, which encodes the b subunit of the electron transport ubiquinol cytochrome C reductase. This mutation also conferred cross-resistance against IP 1, 3 and 4 demonstrating a common target. Gene dosage experiments confirmed M. bovis BCG QcrB as the target where over-expression in M. bovis BCG led to an increase in MIC from 0.5 to >8 µM for IP 3. An acute murine model of TB infection established bacteriostatic activity of the IP series, which await further detailed characterization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The QcrB subunit has been recently shown to be the target of novel imidazo[1,2-a]pyridine inhibitors that are active against M. tuberculosis at low micromolar concentrations (73).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · cited 1×
“Aligned BAM files were supplied as input to the samtools mpileup command using the command-line modifiers ‘‘-C50 -D -S –E’’ and otherwise default settings [30].”
MethodFast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Woese, C. R. (1987) · Microbiological Reviews · doi:10.1128/mr.51.2.221-271.1987 · Cited by 5,042
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544 · cited 2×
“According to TraSH analysis, qcrB is an essential gene [35,36,37].”
BackgroundA Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 2×
“identified utilizing a whole cell phenotypic HTS campaign of a library of more than 70,000 compounds against Mycobacterium smegmatis [11,12,13].”
MethodPossible molecular mechanisms of the protonmotive function of cytochrome systems
Mitchell, P. (1976) · Journal of Theoretical Biology · doi:10.1016/0022-5193(76)90124-7 · Cited by 1,268 · cited 1×
“as it functions by binding to the Qi site, proximal to the BH heme, inhibiting oxidation of the cytochrome b subunit [50].”
BackgroundThe challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042 · cited 2×
“era where TB is untreatable, the discovery of unique drug targets and novel inhibitory compounds can be considered invaluable in terms of meeting the current and future therapeutic needs to relieve the burden of TB cases worldwide [4].”
BackgroundCrystal Structure of the Cytochrome bc 1 Complex from Bovine Heart Mitochondria
Xia, D., Yu, C.-A., Kim, H., Xia, J.-Z., Kachurin, A. M., Zhang, L., Yu, L., & Deisenhofer, J. (1997) · Science · doi:10.1126/science.277.5322.60 · Cited by 946 · cited 1×
“the structure of a myxothiazol-bound cytochrome bc1 complex [51] found the substitution did not fall within the myxothiazol”
BackgroundComprehensive identification of conditionally essential genes in mycobacteria
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231275498 · Cited by 616 · cited 2×
“According to TraSH analysis, qcrB is an essential gene [35,36,37].”
BackgroundThe Population Dynamics and Control of Tuberculosis
Dye, C., & Williams, B. G. (2010) · Science · doi:10.1126/science.1185449 · Cited by 604
Genome plasticity of BCG and impact on vaccine efficacy
Brosch, R., Gordon, S. V., Garnier, T., Eiglmeier, K., Frigui, W., Valenti, P., Dos Santos, S., Duthoy, S., Lacroix, C., Garcia-Pelayo, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700869104 · Cited by 574 · cited 1×
“According to TraSH analysis, qcrB is an essential gene [35,36,37].”
Diarylquinolines target subunit c of mycobacterial ATP synthase
Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio884 · Cited by 547 · cited 2×
“identified utilizing a whole cell phenotypic HTS campaign of a library of more than 70,000 compounds against Mycobacterium smegmatis [11,12,13].”
MethodTotally Drug-Resistant Tuberculosis in India
Udwadia, Z. F., Amale, R. A., Ajbani, K. K., & Rodrigues, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir889 · Cited by 527
Rao, S. P. S., Alonso, S., Rand, L., Dick, T., & Pethe, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711697105 · Cited by 517 · cited 1×
“been shown to be particularly susceptible to inhibitors of the electron transport chain [52].”
BackgroundTahlan, K., Wilson, R., Kastrinsky, D. B., Arora, K., Nair, V., Fischer, E., Barnes, S. W., Walker, J. R., Alland, D., Barry, C. E., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05708-11 · Cited by 504 · cited 3×
“Similarly, the M. tuberculosis inhibitors SQ109 [14,15,16] adamantly ureas [17,18], and benzimidazole [19] were identified following HTS campaigns and chemical lead optimization.”
BackgroundThe Cytochrome bc1 Complex: Function in the Context of Structure
Crofts, A. R. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032102.150251 · Cited by 471
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Grzegorzewicz, A. E., Pham, H., Gundi, V. A. K. B., Scherman, M. S., North, E. J., Hess, T., Jones, V., Gruppo, V., Born, S. E. M., Korduláková, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.794 · Cited by 442 · cited 2×
“The cellular target of SQ109 [20], adamantly ureas [17], pyrrole BM212 [21], and benzimidazoles [19], has recently”
BackgroundProtopopova, M., Hanrahan, C., Nikonenko, B., Samala, R., Chen, P., Gearhart, J., Einck, L., & Nacy, C. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki319 · Cited by 371 · cited 3×
“Similarly, the M. tuberculosis inhibitors SQ109 [14,15,16] adamantly ureas [17,18], and benzimidazole [19] were identified following HTS campaigns and chemical lead optimization.”
BackgroundChristophe, T., Jackson, M., Jeon, H. K., Fenistein, D., Contreras-Dominguez, M., Kim, J., Genovesio, A., Carralot, J.-P., Ewann, F., Kim, E. H., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000645 · Cited by 329
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
Ananthan, S., Faaleolea, E. R., Goldman, R. C., Hobrath, J. V., Kwong, C. D., Laughon, B. E., Maddry, J. A., Mehta, A., Rasmussen, L., Reynolds, R. C., et al. (2009) · Tuberculosis · doi:10.1016/j.tube.2009.05.008 · Cited by 279 · cited 1×
“phenotypic approaches, using High Throughput Screening (HTS) of extensive compound libraries [7,8,9,10].”
MethodDiscovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action
Sacksteder, K. A., Protopopova, M., Barry, C. E., Andries, K., & Nacy, C. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.56 · Cited by 269 · cited 3×
“Similarly, the M. tuberculosis inhibitors SQ109 [14,15,16] adamantly ureas [17,18], and benzimidazole [19] were identified following HTS campaigns and chemical lead optimization.”
BackgroundStanley, S. A., Grant, S. S., Kawate, T., Iwase, N., Shimizu, M., Wivagg, C., Silvis, M., Kazyanskaya, E., Aquadro, J., Golas, A., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb300151m · Cited by 253 · cited 2×
“phenotypic approaches, using High Throughput Screening (HTS) of extensive compound libraries [7,8,9,10].”
BackgroundMethodMmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
La Rosa, V., Poce, G., Canseco, J. O., Buroni, S., Pasca, M. R., Biava, M., Raju, R. M., Porretta, G. C., Alfonso, S., Battilocchio, C., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05270-11 · Cited by 212 · cited 2×
“The cellular target of SQ109 [20], adamantly ureas [17], pyrrole BM212 [21], and benzimidazoles [19], has recently”
BackgroundMmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
Varela, C., Rittmann, D., Singh, A., Krumbach, K., Bhatt, K., Eggeling, L., Besra, G. S., & Bhatt, A. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.03.006 · Cited by 210
Self-citationLee, R. E., Protopopova, M., Crooks, E., Slayden, R. A., Terrot, M., & Barry, C. E. (2003) · Journal of Combinatorial Chemistry · doi:10.1021/cc020071p · Cited by 207 · cited 3×
“Similarly, the M. tuberculosis inhibitors SQ109 [14,15,16] adamantly ureas [17,18], and benzimidazole [19] were identified following HTS campaigns and chemical lead optimization.”
BackgroundTmc207: the First Compound of A New class of Potent Anti-Tuberculosis Drugs
Matteelli, A., Carvalho, A. C., Dooley, K. E., & Kritski, A. (2010) · Future Microbiology · doi:10.2217/fmb.10.50 · Cited by 204 · cited 2×
“identified utilizing a whole cell phenotypic HTS campaign of a library of more than 70,000 compounds against Mycobacterium smegmatis [11,12,13].”
BackgroundMethodElectroporation of Mycobacteria
Parish, T., & Stoker, N. G. (2003) · Electroporation Protocols for Microorganisms · doi:10.1385/0-89603-310-4:237 · Cited by 197
Moraski, G. C., Markley, L. D., Hipskind, P. A., Boshoff, H., Cho, S., Franzblau, S. G., & Miller, M. J. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200036r · Cited by 184 · cited 2×
“The anti-TB properties of the 2,7-dimethylimidazo[1,2a]pyridine-3-carboxamides have also been investigated [26].”
BackgroundDrug‐resistant tuberculosis: Past, present, future
CHIANG, C., CENTIS, R., & MIGLIORI, G. B. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01738.x · Cited by 159
von JAGOW, G., Ljungdahl, P. O., Gräf, P., Ohnishi, T., & Trumpower, B. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82143-7 · Cited by 152
Crofts, A. R., Holland, J. T., Victoria, D. C., Kolling, D. R. J., Dikanov, S. A., Gilbreth, R. N., Lhee, S., Kuras, R., & Guergova-Kuras, M. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.04.037 · Cited by 152
Antituberculosis activity of the molecular libraries screening center network library
Maddry, J. A., Ananthan, S., Goldman, R. C., Hobrath, J. V., Kwong, C. D., Maddox, C. B., Rasmussen, L. A., Reynolds, R. C., Secrist, J. A. I., Sosa, M. I., et al. (2009) · Tuberculosis · doi:10.1016/j.tube.2009.07.006 · Cited by 151 · cited 1×
“phenotypic approaches, using High Throughput Screening (HTS) of extensive compound libraries [7,8,9,10].”
MethodxBASE2: a comprehensive resource for comparative bacterial genomics
Chaudhuri, R. R., Loman, N. J., Snyder, L. A. S., Bailey, C. M., Stekel, D. J., & Pallen, M. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm928 · Cited by 135 · cited 1×
“bovis BCG sequence data were obtained from xBASE [33].”
MethodSelf-citationMak, P. A., Rao, S. P. S., Tan, M. P., Lin, X., Chyba, J., Tay, J. A., Ng, S. H., Tan, B. H., Cherian, J., Duraiswamy, J., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb2004884 · Cited by 126
Niebisch, A., & Bott, M. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210499200 · Cited by 120 · cited 2×
“Following studies by Niebisch and Bott [38], it has been reported that in the absence of a functional QcrC, the expression levels of QcrB are severely reduced, implying that QcrC is required in equimolar amounts for the stable assembly of QcrB.”
BackgroundThe strobilurins, oudemansins, and myxothiazols, fungicidal derivatives of β-methoxyacrylic acid
Clough, J. M. (1993) · Natural Product Reports · doi:10.1039/np9931000565 · Cited by 115 · cited 1×
“Many other inhibitors have been identified that function by the same mechanism as myxothiazol, such as mucidin [43,44,45,46] and strobilurin A [44,47,48].”
BackgroundDaldal, F., Tokito, M. K., Davidson, E., & Faham, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08578.x · Cited by 101
Reynolds, R. C., Ananthan, S., Faaleolea, E. R., Hobrath, J. V., Kwong, C. D., Maddox, C. B., Rasmussen, L. A., Sosa, M. I., Thammasuvimol, E., White, E. L., et al. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.05.005 · Cited by 98
Odell, L. R., Nilsson, M. T., Gising, J., Lagerlund, O., Muthas, D., Nordqvist, A., Karlén, A., & Larhed, M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.045 · Cited by 94 · cited 1×
“Amongst those families, we and others have identified imidazo[1,2-a]pyridines (IP) as simple chemical scaffolds amenable to further lead optimization (Figure 1) [10,23,24,25,26].”
Backgroundvon JAGOW, G., Gribble, G. W., & Trumpower, B. L. (1986) · Biochemistry · doi:10.1021/bi00352a006 · Cited by 90
Kraiczy, P., Haase, U., Gencic, S., Flindt, S., Anke, T., Brandt, U., & von JAGOW, G. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00054.x · Cited by 90
Scherman, M. S., North, E. J., Jones, V. M., Hess, T., Grzegorzewicz, A. E., Kasagami, T., Kim, I.-H., Merzlikin, O., Lenaerts, A. J. M., Lee, R. E., Jr., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.058 · Cited by 81 · cited 1×
“tuberculosis inhibitors SQ109 [14,15,16] adamantly ureas [17,18], and benzimidazole [19] were identi-”
BackgroundEpidemiology of Tuberculosis and HIV: Recent Advances in Understanding and Responses
Martinson, N. A., Hoffmann, C. J., & Chaisson, R. E. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201010-064wr · Cited by 79
Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis
Rullás, J., García, J. I., Beltrán, M., Cardona, P.-J., Cáceres, N., Garcia-Bustos, J., & Angulo‐Barturen, Í. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01423-09 · Cited by 69 · cited 1×
“Dose-response studies in an acute murine infection TB model were carried out as previously described [28].”
MethodArmed Imidazo [1,2-a] Pyrimidines (Pyridines): Evaluation of Antibacterial Activity
Anaflous, A., Benchat, N., Mimouni, M., Abouricha, S., Hadda, T. B., Bali, B. E., Hakkou, A., & Hacht, B. (2004) · Letters in Drug Design & Discovery · doi:10.2174/1570180043398885 · Cited by 56 · cited 2×
“undesirable toxicity in a VERO cell line [23].”
BackgroundElectroporation of Mycobacteria
Parish, T., & Stoker, N. G. (2003) · Humana Press eBooks · doi:10.1385/0-89603-471-2:129 · Cited by 44
Antibiotic mucidin, a new antimycin A-like inhibitor of electron transport in rat liver mitochondria
Šubík, J., Behúň, M., & Musilek, V. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(74)80351-7 · Cited by 34 · cited 1×
“Many other inhibitors have been identified that function by the same mechanism as myxothiazol, such as mucidin [43,44,45,46] and strobilurin A [44,47,48].”
BackgroundFused Heterocycles: Synthesis of Some New Imidazo[1,2-a]- pyridine Derivatives
Kasimoğullari, B. Ö., & Cesur, Z. (2004) · Molecules · doi:10.3390/91000894 · Cited by 24 · cited 1×
“Amongst those families, we and others have identified imidazo[1,2-a]pyridines (IP) as simple chemical scaffolds amenable to further lead optimization (Figure 1) [10,23,24,25,26].”
BackgroundTotally drug‐resistant tuberculosis in India: Who let the djinn out?
Udwadia, Z. F. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02192.x · Cited by 22
Kučera, I., Hedbávný, R., & Dadák, V. (1988) · Biochemical Journal · doi:10.1042/bj2520905 · Cited by 17 · cited 1×
“Another inhibitor, antimycin [49], has been shown to inhibit the cytochrome bc1 complex at a different location to myxothiazol,”
BackgroundUpdate in Tuberculosis and Nontuberculous Mycobacterial Disease 2010
Yew, W. W., Sotgiu, G., & Migliori, G. B. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201102-0325up · Cited by 13
Tokito, M. K., & Daldal, F. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01226.x · Cited by 11
Cited by
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
Pethe, K., Bifani, P., Jang, J., Kang, S., Park, S., Ahn, S., Jiricek, J., Jung, J., Jeon, H. K., Cechetto, J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3262 · Cited by 603
Twenty years of bacterial genome sequencing
Loman, N. J., & Pallen, M. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3565 · Cited by 344
Self-citationNew agents for the treatment of drug-resistant Mycobacterium tuberculosis
Hoagland, D. T., Liu, J., Lee, R. B., & Lee, R. E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.026 · Cited by 328
Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target
ABRAHAMS, K. A., & BESRA, G. S. (2018) · Parasitology · doi:10.1017/s0031182016002377 · Cited by 227
“Phenotypic HTS can reveal anti-TB agents with whole-cell activity and unknown modes of action, having the potential to unveil new biochemical pathways (Abrahams et al. 2012, 2016; Gurcha et al. 2014; Mugumbate et al. 2015).”
Self-citationBald, D., Villellas, C., Lu, P., & Koul, A. (2017) · mBio · doi:10.1128/mbio.00272-17 · Cited by 219
Metadata
- Authors
- Abrahams, K. A., Cox, J. A. G., Spivey, V. L., Loman, N. J., Pallen, M. J., Constantinidou, C., Fernández, R., Alemparte, C., Remuiñán, M. J., Barros, D., Ballell, L., & Besra, G. S.
- Affiliations
- University of Birmingham (GB)
- GlaxoSmithKline (Spain) (ES)
- Corresponding author
- Besra, Gurdyal S.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-31
- Volume
- 7
- Issue
- 12
- Pages
- e52951
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3534098
- OpenAlex
- W1974074976
- Cited by
- 177
- References
- 53
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 12 · 2022: 7 · 2021: 11 · 2020: 18 · 2019: 16 · 2018: 17 · 2017: 16 · 2016: 19 · 2015: 22 · 2014: 20 · 2013: 3
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Aston Publications Explorer (Aston University) (acceptedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- University of Warwick
- European Commission (261378, 2007–2013, FP7 2007-2013)
- Biotechnology and Biological Sciences Research Council (1112080)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Biological Evaluation
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- imidazo[1,2-a]pyridines, Mycobacterium tuberculosis, Mycobacterium bovis BCG, drug resistance, cross-resistance, gene dosage, lead compound identification, murine tuberculosis model, tuberculosis drug discovery
- MeSH terms
- Animals, Antitubercular Agents, Dogs, Humans, Microbial Sensitivity Tests, Microsomes, Liver, Mycobacterium bovis, Mycobacterium tuberculosis, Pyridines, Tuberculosis, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.